PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12869532-6	2003	The latter effect was again antagonized by the addition of EGF to IFNalpha-pretreated cells, probably through the activation of the EGF-->ERK-dependent pathway, since the addition of the specific MEK-1 inhibitor PD098059 abrogated the recovery of intracellular hypusine content induced by EGF in IFNalpha-pretreated cancer cells.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	215-223	epidermal growth factor	Homo sapiens	59-62	
12869532-6	2003	The latter effect was again antagonized by the addition of EGF to IFNalpha-pretreated cells, probably through the activation of the EGF-->ERK-dependent pathway, since the addition of the specific MEK-1 inhibitor PD098059 abrogated the recovery of intracellular hypusine content induced by EGF in IFNalpha-pretreated cancer cells.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	215-223	epidermal growth factor	Homo sapiens	132-135	
12869532-6	2003	The latter effect was again antagonized by the addition of EGF to IFNalpha-pretreated cells, probably through the activation of the EGF-->ERK-dependent pathway, since the addition of the specific MEK-1 inhibitor PD098059 abrogated the recovery of intracellular hypusine content induced by EGF in IFNalpha-pretreated cancer cells.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	215-223	epidermal growth factor	Homo sapiens	132-135